Tessa Lynn Winterton, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-862-6436 |
Dennis Randall Beach, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-862-6436 Fax: 406-862-9978 |
Dr. Kathleen M Lewison, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-862-6436 Fax: 406-862-9978 |
Dr. Bradley Lawrence Kasavana, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-314-0010 Fax: 406-862-9978 |
Mrs. Mirna D Bowden, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-862-6436 Fax: 406-862-9978 |
News Archive
CMC Biologics, a Contract Manufacturing Organization with manufacturing sites in Europe and the USA, today announced the completion of a new state-of-the-art disposable manufacturing facility at its Seattle, WA site. The addition comes as part of a staged major expansion plan, which will add significant production capacity to its existing facility to accommodate a growing demand for cGMP manufacture of biopharmaceuticals.
Nine African countries - Ethiopia, Kenya, Malawi, Nigeria, South Africa, Tanzania, Uganda, Zambia and Zimbabwe – "have lost approximately $2 billion in their investment in doctors who have subsequently migrated abroad," with South Africa and Zimbabwe suffering "the greatest economic losses," according to a study published Friday in BMJ, VOA's "Breaking News" blog reports (11/25).
Twenty-two percent of respondents to a survey have reduced the number of times they visit their physician because of the current economic climate in the U.S., according to the National Association of Insurance Commissioners, the San Francisco Chronicle reports.
For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. GBS is the most common cause of sepsis and meningitis in newborns in the United States, according to the Centers for Disease Control and Prevention (CDC). It can also cause severe illness in pregnant women, the elderly and adults with chronic illnesses.
› Verified 7 days ago